This September, we’re coming together for Childhood Cancer Awareness Month to spread gold, share stories, and shine a light on the osteosarcoma community. Get your gold bows and meet some of the incredible Bow Agent families helping raise awareness and make a difference. We’re looking forward to the next TURBO meeting on September 9 and connecting with members of our community at the State of Sarcoma event during CureFest later this month. Learn how you can become an MIB Awareness Agent and help get rack cards into hospitals and clinics. Plus, our OutSmarting Osteosarcoma Letter of Intent (LOI) submission period opens September 9. Together, every bow, every story, and every action helps move us closer to a better future.
With hope,
The MIB Agents Team
.png)
September is Childhood Cancer Awareness Month, and our annual Gold Bow Campaign brings our community together to raise awareness and show support for the osteosarcoma community.
Our Bow Agent volunteers are helping spread the message in honor of the OsteoWarriors and OsteoAngels who inspire them, sharing Gold Bows and inviting others to join them.
Every bow tells a story. It’s a visible reminder of the children and families affected by osteosarcoma and a symbol of hope, courage, and community. Every bow displayed represents a promise to push for better treatments for kids with cancer and honor the OsteoWarriors and OsteoAngels who inspire us.
Who will you honor? Get a Gold Bow and help raise awareness in your community. Community Bow Packs and Gold Bow Kits are available through the MIB Boutique, making it easy to share Gold Bows with your school, workplace, organization, or community. Display your Gold Bow on your mailbox, front door, office, classroom, tree, or anywhere special to you.
There’s still time to join them and make an impact in your own community!
Together, we can turn our communities gold and shine a light on childhood cancer this September.
.jpeg)
This September, our Bow Agents are helping turn communities gold for Childhood Cancer Awareness Month. In this special spotlight, meet a few of the families behind the bows and learn why they choose to raise awareness, honor their loved ones, and support the osteosarcoma community.
If you have a job posting and you would like it included here, please email kat@mibagents.org.
If you’re managing a patient with relapsed osteosarcoma and want additional perspectives on treatment strategies or clinical trial options, consider presenting the case at MIB Agents TURBO (Tumor Review Board for Osteosarcoma). TURBO meets via Zoom every two months, bringing together a global panel of osteosarcoma experts to review complex cases, exchange insights, and discuss emerging data. It’s a collegial, multidisciplinary forum designed to support clinical decision-making for challenging cases. This educational forum is for medical professionals only; patients and families are welcome to ask their oncologists to present a case on their behalf. Our next meeting is January 13, 2027 at 5p ET.
Join TURBO to request an invite or submit a case.
Thank you to Exelixis for sponsoring TURBO!
Engage with leading researchers and families fighting to make a difference for kids battling sarcomas. This presentation and Q&A is for families, friends, and childhood cancer advocates who have been affected by pediatric sarcomas. Featured panelists include:
Date: Saturday, September 19, 2026
Time: 9:00 am to 10:30 am (Networking session to follow from 10:30 am - 11:30 am)
Location: JW Marriott Hotel, Washington, D.C.
Date: September 9-11, 2026 | Last Day to Register is September 2!
Location: Nationwide Children's Hospital Conference Center
The second biennial Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium, sponsored by the Nationwide Children’s Hospital Division of Hematology, Oncology, and Blood & Marrow Transplant, in collaboration with the Institute for Genomic Medicine, will provide a comprehensive overview across three days of current and developing diagnostic and therapeutic approaches. These sessions, anchored by four plenary speakers, will empower pediatric oncology teams to integrate these new tools at each stage of care of children with cancer.
.png)
September 3 | Subhashini Jagu, PhD
CCDI Data Ecosystem in Action: Enabling Data-Driven Discovery
.png)
September 10 | W. Thomas Cash, MD, MSc
A Phase 1b Study of Tegavivint, a TBL1 Inhibitor, with Gemcitabine in Patients with Relapsed or Refractory Osteosarcoma (TIGER)
.png)
September 24 | Katharine Offer, MD
A phase II clinical trial of IscadorP (Mistletoe extract) as immunotherapy to improve event-free survival in patients with relapsed resectable osteosarcoma
.png)
%20(1).png)
The 2027 LOI submission period will open on September 9, 2026. Final applications are due by October 16th by 11:59 p.m. Approved LOIs will be notified in early December and invited to submit a full application by January 25, 2027.
Please email kat@mibagents.org with any questions.
Learn More About OutSmarting Osteosarcoma
We're heading into the last few months of 2026, but there is still so much work to be done - and so many opportunities to Make It Better!
From supporting an OsteoWarrior through programs, helping clinicians connect, and bringing advocates and researchers together, our programs are only possible because of the supporters in our community.
We still have several 2026 sponsorship opportunities available.
To become an MIB Agents Sponsor, please reach out to Hannah@mibagents.org.
Thank you to MedPacto for sponsoring NextGen member and OsteoWarrior Matthew Ceelen's attendance at the ACCELERATE conference in Brussels! We are still looking for sponsors to support the rest of our JAB and NextGen members' conference travel. If you are interested in becoming an MIB Agents sponsor, please email hannah@mibagents.org.
